Membership | Public Reports | Settlement Overview | Use of ORF Funds
About
Maryland’s Opioid Restitution Fund (ORF) was created in 2019 to receive all funds awarded to the State of Maryland through legal settlements with prescription opioid manufacturers and distributors. In 2022, Maryland established the ORF Advisory Council to provide recommendations regarding the use of those funds.
For questions regarding the ORF Advisory Council, email StopOverdose@maryland.gov.
Resources
- State-Subdivision Agreement (January 2022 – Janssen)
- State-Subdivision Agreement (April 2023 – Teva, Allergan, & Walmart)
- Janssen Settlement – Exhibit E (allowable uses)
- Legislative Mandate (updated in 2024 with Senate Bill 751)
- 2023 ORF Advisory Council Funding Recommendations
Next ORF Advisory Council Meeting – Monday, October 21, 2024 (virtual)
Time: 3:00–4:00 p.m.
Meeting Link | Agenda (coming soon)
Vacancy Announcement
The Opioid Restitution Fund Advisory Council is currently accepting applications to fill one membership vacancy in 2024. By law, the ORF Advisory Council is required to have broad representation from individuals with diverse backgrounds. You can read more about the responsibilities of the council and its membership requirements at https://mgaleg.maryland.gov/mgawebsite/Laws/StatuteText?article=gsf§ion=7-331&enactments=false.
If you are interested in serving on the ORF Advisory Council, please see the vacancy details below.
Current Openings:
Governor’s Appointment
- An individual who represents a community-based opioid treatment program.
To apply for this vacancy, please complete the online application through the Governor’s Appointments Office: https://md.accessgov.com/governors-office/Forms/Page/v2/profile/1
Past Meetings
Regular Meeting – Monday, September 23, 2024 (virtual)
Agenda | Meeting Recording
Click here to view meeting minutes from past ORF Advisory Council meetings.
Stay in Contact!
To receive notifications regarding Maryland’s overdose crisis response efforts, please complete the following form to be added to our mailing list.